Scott J. Leffler is Chief Financial Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 163,865 shares of MYGN, which is worth approximately $2.19 Million. The most recent transaction as insider was on Mar 14, 2024, when has been sold 46,095 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
0% 3M change
n/a 12M change
Total Value Held $2.19 Million

Scott J. Leffler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2024
BUY
Grant, award, or other acquisition
-
46,095 Added 21.95%
163,865 Common Stock
Jan 29 2024
BUY
Grant, award, or other acquisition
-
117,770 Added 50.0%
117,770 Common Stock

Also insider at

SHC
Sotera Health Co Healthcare
CLOV
CLOVER HEALTH INVESTMENTS, CORP. Healthcare
SJL

Scott J. Leffler

Chief Financial Officer
Franklin, TN

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN